Cargando…

Low-Dose IL-2 Therapy in Autoimmune and Rheumatic Diseases

Regulatory T cells (Treg) are crucial for the maintenance of peripheral tolerance and for the control of ongoing inflammation and autoimmunity. The cytokine interleukin-2 (IL-2) is essentially required for the growth and survival of Treg in the peripheral lymphatic tissues and thus plays a vital rol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Graßhoff, Hanna, Comdühr, Sara, Monne, Luisa R., Müller, Antje, Lamprecht, Peter, Riemekasten, Gabriela, Humrich, Jens Y.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8047324/ https://www.ncbi.nlm.nih.gov/pubmed/33868284 http://dx.doi.org/10.3389/fimmu.2021.648408

Ejemplares similares

Dysregulation and chronicity of pathogenic T cell responses in the pre-diseased stage of lupus
por: Ohmes, Justus, et al.
Publicado: (2022)

When natural antibodies become pathogenic: autoantibodies targeted against G protein-coupled receptors in the pathogenesis of systemic sclerosis
por: Akbarzadeh, Reza, et al.
Publicado: (2023)

Autoantibodies as Biomarker and Therapeutic Target in Systemic Sclerosis
por: Graßhoff, Hanna, et al.
Publicado: (2022)

Natural Treg and role of IL-2 in lupus
por: Riemekasten, Gabriela, et al.
Publicado: (2011)

Regulatory T cells inhibit autoantigen-specific CD4(+) T cell responses in lupus-prone NZB/W F1 mice
por: Rosenberger, Stefan, et al.
Publicado: (2023)

Transfer of PBMC From SSc Patients Induces Autoantibodies and Systemic Inflammation in Rag2-/-/IL2rg-/- Mice
por: Yue, Xiaoyang, et al.
Publicado: (2021)

Potential effects of shift work on skin autoimmune diseases
por: Stenger, Sarah, et al.
Publicado: (2023)

Targeting Syk in Autoimmune Rheumatic Diseases
por: Deng, Guo-Min, et al.
Publicado: (2016)

Der außergewöhnliche Nachahmer einer Polymyositis
por: Jendrek, S. T., et al.
Publicado: (2022)

Pathogenetic and Clinical Aspects of Anti-Neutrophil Cytoplasmic Autoantibody-Associated Vasculitides
por: Lamprecht, Peter, et al.
Publicado: (2018)

The Role of IgG4 in Autoimmunity and Rheumatic Diseases
por: Maslinska, Maria, et al.
Publicado: (2022)

Role of the IL-23/IL-17 Pathway in Rheumatic Diseases: An Overview
por: Schinocca, Claudia, et al.
Publicado: (2021)

IL-2 Therapy Diminishes Renal Inflammation and the Activity of Kidney-Infiltrating CD4+ T Cells in Murine Lupus Nephritis
por: Rose, Angelika, et al.
Publicado: (2019)

Cell-Free DNA as a Biomarker in Autoimmune Rheumatic Diseases
por: Duvvuri, Bhargavi, et al.
Publicado: (2019)

CD4+Foxp3+ regulatory T cells prolong drug-induced disease remission in (NZBxNZW) F1 lupus mice
por: Weigert, Olivia, et al.
Publicado: (2013)

The Lübeck Medication Satisfaction Questionnaire—A Novel Measurement Tool for Therapy Satisfaction
por: Matrisch, Ludwig, et al.
Publicado: (2023)

Autoimmunity to Sphingosine-1-Phosphate-Receptors in Systemic Sclerosis and Pulmonary Arterial Hypertension
por: Gluschke, Hans, et al.
Publicado: (2022)

The Uses and Misuses of Multiplex Autoantibody Assays in Systemic Autoimmune Rheumatic Diseases
por: Satoh, Minoru, et al.
Publicado: (2015)

Granulomatous Inflammation in ANCA-Associated Vasculitis
por: Müller, Antje, et al.
Publicado: (2021)

The Complement System in the Pathophysiology of Pregnancy and in Systemic Autoimmune Rheumatic Diseases During Pregnancy
por: Chighizola, Cecilia Beatrice, et al.
Publicado: (2020)

COVID-19 in Association With Development, Course, and Treatment of Systemic Autoimmune Rheumatic Diseases
por: Lakota, Katja, et al.
Publicado: (2021)

Autoimmune and Rheumatic Manifestations Associated With COVID-19 in Adults: An Updated Systematic Review
por: Tang, Kuo-Tung, et al.
Publicado: (2021)

Immunogenic cell death as driver of autoimmunity in granulomatosis with polyangiitis
por: Brieske, Christoph, et al.
Publicado: (2022)

Elevated IL-19 Serum Levels in Patients With Pernicious Anemia and Autoimmune Gastritis
por: Della Bella, Chiara, et al.
Publicado: (2022)

Phenotyping of Adaptive Immune Responses in Inflammatory Diseases
por: Humrich, Jens Y., et al.
Publicado: (2020)

Obesity as a Risk and Severity Factor in Rheumatic Diseases (Autoimmune Chronic Inflammatory Diseases)
por: Gremese, Elisa, et al.
Publicado: (2014)

T-Cell Compartmentalization and Functional Adaptation in Autoimmune Inflammation: Lessons From Pediatric Rheumatic Diseases
por: Mijnheer, Gerdien, et al.
Publicado: (2019)

Insights Gained and Future Outlook From scRNAseq Studies in Autoimmune Rheumatic Diseases
por: Zheng, Zihan, et al.
Publicado: (2022)

Research progress on the clinical application and mechanism of iguratimod in the treatment of autoimmune diseases and rheumatic diseases
por: Long, Zhiyong, et al.
Publicado: (2023)

Autoantibodies in Serum of Systemic Scleroderma Patients: Peptide-Based Epitope Mapping Indicates Increased Binding to Cytoplasmic Domains of CXCR3
por: Recke, Andreas, et al.
Publicado: (2018)

Effect of low-dose rituximab treatment on autoimmune nodopathy with anti-contactin 1 antibody
por: Hou, Ying, et al.
Publicado: (2022)

IL-2-Agonist-Induced IFN-γ Exacerbates Systemic Anaphylaxis in Food Allergen-Sensitized Mice
por: Link, Christopher W.M., et al.
Publicado: (2020)

Rheumatic Heart Disease: Molecules Involved in Valve Tissue Inflammation Leading to the Autoimmune Process and Anti-S. pyogenes Vaccine
por: Guilherme, Luiza, et al.
Publicado: (2013)

What Makes Antibodies Against G Protein-Coupled Receptors so Special? A Novel Concept to Understand Chronic Diseases
por: Riemekasten, Gabriela, et al.
Publicado: (2020)

Gastric Th17 Cells Specific for H(+)/K(+)-ATPase and Serum IL-17 Signature in Gastric Autoimmunity
por: Della Bella, Chiara, et al.
Publicado: (2022)

IL-37 restrains autoimmune diseases
por: Ye, Liang, et al.
Publicado: (2015)

Role of the Pruritic Cytokine IL-31 in Autoimmune Skin Diseases
por: Gibbs, Bernhard F., et al.
Publicado: (2019)

Roles of IL-25 in Type 2 Inflammation and Autoimmune Pathogenesis
por: Deng, Chong, et al.
Publicado: (2021)

Antigen-Specific Regulatory T Cells and Low Dose of IL-2 in Treatment of Type 1 Diabetes
por: Pham, Minh N., et al.
Publicado: (2016)

Effect of low dose IL-2 loaded chitosan nanoparticles on natural killer and regulatory T cell expression in experimentally induced autoimmune type 1 diabetes mellitus
por: Aboelnazar, Salma, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rpq1jn5jjv7mo2vv8ocvm91lgl